Spinal cord injury research institute bulking up on PFCsRSS Feed

A leading research institution for spinal cord injury and traumatic brain injury has made a "significant order" for a type of ultra-oxygen carrying perfluorocarbon-based product.

Virginia Commonwealth University (VCU) has ordered the PHER-O2 product from bio-pharmaceutical firm Sanguine.

The VCU Reanimation Engineering Shock Center is currently involved in "very promising" pre-clinical trials involving perfluorocarbons (PFCs) relating to spinal cord injury and traumatic brain injury, as well as studies on organs.

It is hoped that the trials involving PFCs could speed up research and advancements in treatments of neurological conditions.

"The research to be conducted with the PHER-O2 is expected to significantly advance the market acceptance of PFCs and lead to many important products and treatment methods for critical diseases and injuries," explained Sanguine spokesman Frank Marra.

PFCs are currently used commonly in eye surgery as temporary replacements for the vitreous humour in retinal detachment operations.

News from Serious Law, specialist spinal injury compensation solicitors

Posted by Matthew Heap

Brain injury risk targeted by NFL

28 July 2010

The risk of brain injury resulting from repeated concussions has been acknowledged by the US National Football League (NFL) with a new poster campaign.The document, which will be required to be hung in...

Read More...

Brain injury children 'can't tell stories'

27 July 2010

A child who has suffered a brain injury may find it hard to tell stories despite other language skills catching up with other children, a new study has claimed.The team from the University of Chicago examined...

Read More...

Bowling recognised with brain and spinal injury award

26 July 2010

A woman has won an award for her services to people with brain and spinal injuries.Annette Bowling was recognised by the Brain and Spinal Injury Trust Fund Commission with the annual Pathfinder Award for...

Read More...